Bichler et al (1990) reported that when serum TNFα level was measured in 29 RCC patients, patients with metastatic disease could exhibit increased levels of serum TNF and that the decrease in TNF may be associated with a better prognosis. This evidence concerns the gene TNF and metastatic neoplasm.